The executive chief of the European Union has said that the EU will donate a further 200 million COVID-19 vaccine doses to poorer countries and close gaps in its own vaccination coverage, Reuters news agency reported on Wednesday.
Ursula von der Leyen was quoted as telling the European Parliament in a speech in that the EU's first pandemic priority was to speed up global vaccination, given less than 1% of doses globally administered had been in low-income countries.
She said that European Commission will donate 200 million COVID-19 vaccine doses to low-income countries by the middle of next year, on top of the 250 million doses already pledged.
The European Commission president also said she saw "worrisome divergences" between the rates of vaccination in EU member states, adding that the bloc had secured 1.8 billion further vaccine doses to cover more initial and booster shots.
Von der Leyen added that the EU was setting up a health emergency response authority, designed to improve the bloc's response to cross-border health threats.
She also proposed that the EU invest EUR50bn by 2027 to improve its preparedness and resilience to future health threats.
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption
Essa Pharma sets ex-dividend date and due bill trading for USD80m capital return
BioDlink's bevacizumab injection secures Colombia and Pakistan marketing authorisation
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
Everest Medicines expands I-MAB investment
Perrigo Announces Quarterly Dividend
Ridgetech reports net income of USD10.20m in fiscal year 2025
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
Perrigo to divest Dermacosmetics business for up to EUR327m
CVS Health declares quarterly dividend USD0.665 per share
Lilly declares dividend of USD1.50 for Q3
Bavarian Nordic sells US Priority Review Voucher for USD160m